Final quality assessment scores for all studies that met the inclusion criteria. by Jessica Craig (409538)

This supplement contains a complete list of all terms that were significantly enriched using our transcriptomic data. by Amberleigh E. Henschen (3257235)

Tables showing the peaks of all significant clusters found within our frontal masks that are reported in the main text. by Caroline I. Jahn (14522732)

All relevant data. by Nana Takahashi (9999164)

Deletion of <i>sagA</i> alone results in a decrease in nasopharyngeal infection. by Blake A. Shannon (14197601)

Raw data values from all experiments. by Elizabeth L. Graham (18462018)

Baseline characteristics of all implanted patients. by Monique E. A. M. van Kleef (8783282)

Average effect size decreased as sample size increased for all types of analyses (<i>p</i> < .001). by Luke J. Ney (12621627)

Comparison of the performance of the 10 CV (10 fold cross validation) model and the permutated model. by Sakuni Rankothgedera (11457923)

All female hyper-methylated regions. by Andrey Höglund (3292482)

All-variable XGBoost model on the <i>significant illness</i> binary using the all-owner dataset. by Richard Barrett-Jolley (739341)

“…<p>(a) Receiver operating characteristic curve of a prediction model containing all variables (owner, animal and healthcare). This shows the increasing true positive and false positive rates, with decrease of the threshold probability for prediction of <i>significant illness</i>. …”

The slope for all significant factors on the number of steps before a fall across all three speeds. by Amy Mitchell (3208905)

Stability parameters for SpGrx3 WT and mutants. by Trang Van Tran (16913946)

Subjects:

Kinetic parameters of SpGrx3 WT and mutants. by Trang Van Tran (16913946)

Subjects:

<i>T</i>_m values of SpGrx3 WT and mutants. by Trang Van Tran (16913946)

Subjects:

General study, patient, and CPET characteristics of all included studies. by Nabeela Arbee-Kalidas (17598969)

Title and publication information for all human health studies that met inclusion criteria. by Jessica Craig (409538)

Title and publication information for all animal health studies that met inclusion criteria. by Jessica Craig (409538)

Baseline characteristics of all participants. by Vivian Feng (11731448)

Phosphorylation as an Effective Tool to Improve Stability and Reduce Toxicity of Antimicrobial Peptides by Zufang Ba (11036420)

“…Among them, W₃BipY₈-P stood out as the most promising peptide, exhibiting similar antibacterial activity as its unphosphorylated analog W₃BipY₈ but with significantly reduced hemolytic activity (19-fold decrease), cytotoxicity (3.3-fold decrease), and an extended serum half-life 6.3 times longer than W₃BipY₈. …”